Family-office and private-investor capital

Who invests private equity in cannabis businesses?

With institutional equity largely absent, the money comes from individuals and families: high-net-worth individuals, family offices, small private funds, and operators reinvesting their own proceeds. Pension funds, most private equity firms, and bank-affiliated investors generally stay out of plant-touching companies while marijuana is federally illegal for adult use.

The backdrop is a shortage. The Viridian Cannabis Deal Tracker, as reported by MJBizDaily, put debt at about 94.8% of capital raised by U.S. licensed operators in 2025, and nine of the ten largest raises that year were debt. A public cannabis lender told investors in August 2026 that access to equity capital in the industry remains challenged. For a buyer, that means equity is available mainly through personal relationships, and it is expensive.

What private investors tend to look for, in general practice:

• Limited-licence states, where a capped licence count protects margins. See limited-license vs open-market states.
• Owned real estate, or the chance to own it and lease it to the operator.
• Clean books that reconcile to track-and-trace data and tax filings.
• An operator with a record, since the investor usually cannot run the business.
• A believable exit, whether a sale, a refinancing, or distributions.

How is a private raise done legally?

Selling shares, membership units, or profit-sharing notes to investors is a sale of securities. It must be registered with the SEC or fit an exemption. Nearly all private cannabis raises use Regulation D.

	Rule 506(b)	Rule 506(c)
Amount	Unlimited	Unlimited
Advertising or general solicitation	Not allowed	Allowed
Who can buy	Accredited investors, plus up to 35 non-accredited investors who are financially sophisticated	Accredited investors only
Verification	Investor self-certification is common practice	Issuer must take reasonable steps to verify accredited status
Disclosure	Prescribed disclosure documents and financial statements if any non-accredited investor takes part	Anti-fraud rules apply; no prescribed format
Form D	Within 15 days after the first sale	Within 15 days after the first sale
Bad-actor rule	Applies	Applies
State law	Registration pre-empted; states may require notice filings and fees	Same

Who is accredited. Under the SEC’s definition, an individual qualifies with net worth over $1 million excluding the primary residence, or income over $200,000 (or $300,000 with a spouse or partner) in each of the past two years with the same expected this year. Entities generally qualify with more than $5 million in assets or investments, or if every equity owner is accredited. A family office qualifies with more than $5 million in assets.

Three practical points:

1. Keep non-accredited investors out if you can. One non-accredited investor in a 506(b) offering triggers formal disclosure requirements that cost real legal fees.
2. An exemption from registration is not an exemption from fraud rules. Investors must be told the material risks. In cannabis those include federal illegality of adult-use marijuana, 280E, the lack of bankruptcy protection, licence non-transferability, and the limits on any exit.
3. The bad-actor rule and the cannabis regulator overlap. A person with a disqualifying securities or criminal history can sink both the exemption and the licence application.

When do investors have to be disclosed to the cannabis regulator?

Almost always in some form, and before the money moves. States draw the lines differently.

State	Rule	What it means for an investor
California	4 CCR 15003 and 15004	A person with an aggregate 20% or more is an owner, with full disclosure. Stakes held through several entities are added together, and people who control an investing entity are looked through. Smaller holders and lenders are financial interest holders and must be listed.
Washington	WAC 314-55-035	Source of all funds, including money from financiers, must be disclosed before it is invested. A financier may not take a share of revenue or exercise control without approval.

Other states use their own thresholds and labels, such as true party of interest, controlling person, or person with direct or indirect control. The framework and more state examples are on true party of interest and financial interest rules. Some states also cap how many licences one person may hold an interest in, which can catch an investor with stakes in several operators; see ownership caps and residency rules by state.

The consequences for a raise:

• Add regulator time to the closing timetable. Adding owners after the acquisition is its own change of ownership filing in many states.
• Pre-screen every investor. Ask about criminal history, prior licence discipline, tax compliance, and interests in other cannabis licensees before accepting a subscription.
• Expect some investors to walk. Family offices value privacy. Fingerprints, personal financial disclosure, and a public licence record are deal-breakers for some.
• Watch the structure. Conversion rights, profit participation, vetoes, and board seats can lift a passive investor into the owner category.
• Non-citizens need separate advice. See immigration consequences for non-citizen owners.

What does investor capital cost?

More than debt. Equity investors rank behind every lender and cannot foreclose, so they expect a return above the 13% to 16% yields that public cannabis lenders reported in mid-2026. No reliable public survey of private cannabis equity returns exists, so this page does not quote one. What can be said is how the cost shows up:

• Dilution. The investor’s percentage, applied to every future dollar of value.
• Preferred return. A priority distribution to investors before the operator shares in profit.
• Control terms. Approval rights over budgets, debt, and a sale. These often matter more than the headline percentage.
• Exit rights. Drag-along, tag-along, and put rights that decide who controls the timing of a sale.

Illustrative: equity versus more debt

A buyer needs $1.2 million to complete a $4.0 million acquisition. The business produces $700,000 a year after tax and before financing.

	Option A: investor equity	Option B: private loan
Terms	$1.2 million for 35% of the company	$1.2 million at 15%, interest-only
Annual cost in a normal year	35% of distributable cash	$180,000 interest
Cost if cash flow falls to $300,000	35% of whatever is distributed; no default	$180,000 still due; default risk
Cost on a $6.0 million sale in year five	Investor receives about $2.1 million of equity value	Loan repaid at $1.2 million

Equity is cheaper in bad years and much more expensive in good ones. It also brings a partner. Debt is the reverse. Many buyers blend the two, and use a seller note before either. All the sources are compared on cannabis acquisition financing options.

What should be settled before approaching investors?

1. A signed letter of intent or at least agreed headline terms with the seller, under an NDA that lets you share information with funding sources.
2. A sources-and-uses table and a model that shows cash flow after 280E taxes.
3. A written summary of the state’s ownership and disclosure rules, so investors know what they are signing up for.
4. Securities counsel engaged, offering documents drafted, and a plan for Form D and state notice filings.
5. An operating agreement that the regulator will accept, with no hidden control rights.
6. A realistic exit discussion. Buyers of cannabis businesses are limited, and MSO stock is not cash; see is a cannabis business a good investment?.

This is educational material, not legal, securities, tax, or investment advice, and it is not an offer to sell or a solicitation to buy any security. A business broker does not raise investor capital; securities offerings should be handled with qualified securities counsel.